Twist Bioscience Corporation - Laporan Laba Rugi (TTM)

Twist Bioscience Corporation
US ˙ NasdaqGS ˙ US90184D1000

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Twist Bioscience Corporation menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 90 101 113 127 132 146 163 184 204 216 228 235 245 262 277 295 313 330 348 362
Change (%) 12.21 11.78 12.22 4.35 10.47 11.58 12.93 10.51 6.01 5.59 3.35 4.09 7.04 5.76 6.39 6.02 5.50 5.30 4.20
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 61 66 71 76 81 90 100 110 119 122 134 145 155 168 171 176 180 183 185 184
Change (%) 7.12 8.31 6.26 6.50 11.03 11.94 10.02 8.24 2.00 9.82 8.13 7.50 8.43 1.63 2.54 2.31 1.86 1.28 -0.77
% of Revenue 68.15 65.06 63.04 59.69 60.92 61.23 61.43 59.85 58.62 56.40 58.67 61.38 63.39 64.21 61.71 59.47 57.39 55.41 53.30 50.76
Gross Operating Profit 29 35 42 51 52 57 63 74 84 94 94 91 90 94 106 120 133 147 162 178
Change (%) 23.10 18.24 22.39 1.17 9.60 11.01 17.57 13.88 11.68 0.10 -3.45 -1.32 4.64 13.18 12.59 11.46 10.41 10.29 9.87
% of Revenue 31.85 34.94 36.96 40.31 39.08 38.77 38.57 40.15 41.38 43.60 41.33 38.62 36.61 35.79 38.29 40.53 42.61 44.59 46.70 49.24
SG&A 103 106 113 125 136 158 178 197 213 204 204 197 190 200 202 213 218 222 230 236
Change (%) 2.31 6.81 10.62 8.86 16.41 12.39 10.81 8.08 -4.12 -0.02 -3.74 -3.44 5.54 0.83 5.32 2.70 1.53 3.63 2.86
% of Revenue 114.61 104.51 99.87 98.45 102.70 108.22 109.01 106.96 104.61 94.62 89.60 83.45 77.41 76.33 72.76 72.03 69.78 67.15 66.09 65.24
R&D 43 47 52 61 69 78 93 110 120 129 125 113 107 99 96 93 91 89 89 84
Change (%) 8.61 11.05 18.11 12.74 12.49 19.87 18.25 9.23 7.16 -2.99 -9.85 -5.20 -7.62 -3.27 -2.15 -2.79 -1.97 -0.26 -4.98
% of Revenue 47.73 46.20 45.90 48.31 52.20 53.15 57.10 59.79 59.10 59.74 54.89 47.88 43.61 37.64 34.42 31.66 29.03 26.97 25.55 23.30
OpEx 208 218 236 262 286 325 371 417 453 455 463 454 452 467 469 482 489 494 504 505
Change (%) 5.04 8.17 10.95 9.08 13.95 14.05 12.46 8.43 0.49 1.77 -1.96 -0.39 3.42 0.25 2.78 1.49 1.00 2.06 0.14
% of Revenue 230.50 215.77 208.81 206.45 215.81 222.60 227.55 226.60 222.33 210.77 203.16 192.72 184.41 178.18 168.89 163.17 156.20 149.54 144.94 139.30
Operating Income -118 -117 -123 -135 -153 -179 -208 -233 -249 -239 -235 -218 -207 -205 -191 -186 -176 -164 -156 -142
Change (%) -0.46 5.06 9.79 13.53 16.95 16.07 12.10 6.78 -4.02 -1.67 -7.11 -5.24 -0.86 -6.80 -2.46 -5.67 -7.01 -4.48 -8.88
% of Revenue -130.50 -115.77 -108.81 -106.45 -115.81 -122.60 -127.55 -126.60 -122.33 -110.77 -103.16 -92.72 -84.41 -78.18 -68.89 -63.17 -56.20 -49.54 -44.94 -39.30
Interest Expense -1 -1 -1 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0
Change (%) -16.52 -18.26 -20.48 -14.05 -25.07 -24.36 -34.13 -41.61 -31.25 -47.27 3.45 -83.33 -20.00 -50.00 -50.00 2,800.00 82.76 267.92 -85.13
% of Revenue -0.87 -0.65 -0.48 -0.34 -0.28 -0.19 -0.13 -0.07 -0.04 -0.03 -0.01 -0.01 -0.00 -0.00 -0.00 -0.00 -0.01 -0.02 -0.06 -0.01
Net Income -140 -117 -123 -135 -152 -165 -188 -208 -218 -214 -213 -209 -205 -206 -192 -220 -209 -197 -191 -85
Change (%) -16.25 5.25 9.59 12.52 8.33 13.81 10.92 4.75 -1.72 -0.71 -1.47 -2.33 0.58 -6.64 14.66 -5.26 -5.47 -3.12 -55.43
% of Revenue -155.31 -115.92 -109.15 -106.59 -114.94 -112.70 -114.96 -112.91 -107.02 -99.23 -93.32 -88.97 -83.48 -78.44 -69.24 -74.63 -66.69 -59.76 -54.98 -23.51

Source: Capital IQ

Other Listings
IT:1TWST € 23.95
DE:0ME € 21.54
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista